Literature DB >> 10792065

Prostate-specific membrane antigen: present and future applications.

S S Chang1, P B Gaudin, V E Reuter, W D Heston.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10792065     DOI: 10.1016/s0090-4295(99)00600-7

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  6 in total

1.  Preclinical evaluation of BAY 1075553, a novel (18)F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer.

Authors:  Ralf Lesche; Georg Kettschau; Alexey V Gromov; Niels Böhnke; Sandra Borkowski; Ursula Mönning; Christa Hegele-Hartung; Olaf Döhr; Ludger M Dinkelborg; Keith Graham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-17       Impact factor: 9.236

2.  Complementary medicine, chemoprevention, and staging of prostate cancer.

Authors:  E David Crawford
Journal:  Rev Urol       Date:  2003

Review 3.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

Review 4.  Circulating biomarkers for prostate cancer.

Authors:  Thomas Steuber; Pauliina Helo; Hans Lilja
Journal:  World J Urol       Date:  2007-03-08       Impact factor: 4.226

5.  18F-Prostate-Specific Membrane Antigen and 18F-Fluorodeoxyglucose PET/CT Unmasked the Characteristics of Prostate Lymphoma: A Case Report and Literature Review.

Authors:  Fan Jiang; Junjie Fan; Hua Liang; XiaoYi Duan; Dalin He; Kaijie Wu
Journal:  Front Med (Lausanne)       Date:  2022-04-06

Review 6.  PSMA-Targeting Positron Emission Agents for Imaging Solid Tumors Other Than Non-Prostate Carcinoma: A Systematic Review.

Authors:  Christophe Van de Wiele; Mike Sathekge; Bart de Spiegeleer; Pieter Jan de Jonghe; Laurence Beels; Alex Maes
Journal:  Int J Mol Sci       Date:  2019-10-02       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.